RAKS PHARMA PVT LTD (DIVISON OF AMNEAL PHARMACEUTICALS) HIRING CANDIDATES FOR QC DEPARTMENT @ VIZAG

 

ABOUT COMPANY :

We at Raks are dedicated to develop and manufacture active pharmaceutical ingredients and intermediates. We are committed to create value through intellectual property, quality systems and customer relation across the globe. We are research driven company providing cost effective and environmental friendly technologies with safety and quality as primary focus.

M/s. RAKS Pharma was conceptualized to become a significant API player so as to manufacture & supply APIs & Drugs Intermediate to Regulated & Non-Regulated Market from its present manufacturing site in Visakhapatnam (Andhra Pradesh), and upcoming unit in Dahej (Gujarat) India.

Raks is an interesting blend of consistency in maintaining both quality standard and growth in terms of addition of new products to its existing list of API's and intermediates. To realize this goal it has a team of experienced, dedicated and highly motivated professionals in all fields of the business.

Founded by a group of highly committed Technocrats in year 2009, today Raks Pharma is a partner of choice for pharmaceutical companies across the globe to source Active Pharmaceuticals Ingredients and their intermediates.

For more updates follow 

www.globalpharmanews.co.in

To get global pharma news updates in whatsapp please 

CLICK HERE

NEUHEIT PHARMA TECHNOLOGIES PVT LTD WALK IN INTERVIEW ON 08th, AUGUST, 2021 @ HYDERABAD

ABOUT COMPANY :

Neuheit Pharma Technologies Private Ltd is a Hyderabad based Research & Development Company specializing in the research and development of pharmaceutical drug products (for marketing authorizations in global regulated markets). The company is pro-actively involved in development of complex generic and differentiated products from ideation to commercialization. It also offers consultancy services in all disciplines of pharmaceutical product development including pharmacokinetic design and modeling with emphasis on bioequivalence and bioavailability studies. Our key strength is developing novel approaches for bio/clinical waiver strategies and 505(b) (2) product ideational development.  We intend to grow in the ever expanding global pharmaceutical industry by collaborating with strategic partners in different disciplines of formulations.

Neuheit Pharma Technologies Private Ltd established in 2013, is a Research & Development company that provides Creative Solutions for Human Suffering by developing complex generics and innovative products that offer clinical advantage to the patient. The company is started with solid orals and expanded to liquid orals & Injectables (general and high potent).  Currently expansion is in progress towards the development of dermal/topical R & D facility. Separate manufacturing facility for solid orals for regulatory market is also in progress.

For more updates follow 

www.globalpharmanews.co.in

To get global pharma news updates in whatsapp please 

CLICK HERE

HETERO LABS LTD WALK IN INTERVIEW FOR FRESHERS ON 1st, AUGUST, 2021 @ HYDERABAD

ABOUT COMPANY :

Hetero is a globally renowned vertically integrated pharmaceutical player engaged in research and development, manufacturing, and marketing of high-quality chemical and biologic medicines across diverse therapeutic areas. Backed by 27+ years of expertise in the pharmaceutical industry, Hetero’s strategic business areas spread across APIs, Global Generics, Biosimilars and Custom Pharmaceutical Services. The company is among the largest producers of Active Pharmaceutical Ingredients (APIs) in the world.

Hetero has 36 state-of-the-art manufacturing facilities strategically located worldwide, which has been approved by top pharma regulatory bodies of the world. Our portfolio includes 300+ products encompassing major therapeutic categories such as HIV/AIDS, Oncology, Cardiovascular, Neurology, Hepatitis, Nephrology etc. Hetero has a strong global presence in over 126 countries and focusses on making affordable medicines accessible to patients worldwide.

Over the years, Hetero has established its strong leadership in ARVs and Antiviral therapies and caters to 40% of existing global demand for Anti-Retroviral (ARV) APIs and Finished Dosage Forms (FDFs) used in HIV/AIDS treatment.

A track record of responding to Global Public Health Emergencies

The highlight of Hetero’s 27+ years of existence has been its responsive actions to mitigate pandemics and life-threatening diseases afflicting communities across the world. By partnering with innovators for developing Oseltamivir to fight against Swine Flu Pandemic to enabling access to affordable Hepatitis C medicines in underdeveloped countries, Hetero has always endeavoured to do its bit at times of global health crises and save precious lives.

Since the onset of the Covid-19 pandemic, Hetero has been proactive in responding to the various challenges surrounding it. It has been the first company to launch the licensed version of generic Remdesivir under the brand name ‘Covifor’ in India for treating severely infected patients and followed it up with Favipiravir (Favivir) to provide succor to those affected by mild and moderate symptoms. As of today, the company is among the largest manufacturers of Remdesivir globally.

Illustrating its continuing commitment to play its part in the global fight against the pandemic, Hetero has entered into an agreement with the Russian Direct Investment Fund (RDIF) as a manufacturing partner for producing 100 million doses of the Sputnik V vaccine per year. This development also showcases Hetero’s enduring spirit of collaboration and penchant for contributing to global health and well-being.

For more updates follow 

www.globalpharmanews.co.in

To get global pharma news updates in whatsapp please 

CLICK HERE

FIDELITY HEALTH SERVICES HIRING CANDIDATES FOR PHARMACOVIGILANCE DEPARTMENT @ MUMBAI

For more updates follow 

www.globalpharmanews.co.in

To get global pharma news updates in whatsapp please 

CLICK HERE

ALKEM LABORATORIES LTD WALK IN INTERVIEW ON 7th, AUGUST, 2021 @ DAMAN

ABOUT COMPANY :

A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a spark that could ignite a thousand more ideas. And it did!

Looking back at our 4 decade, illustrious journey, that one small idea has Not only triggered us to become one of India’s largest generic and specialty pharmaceutical company but also, create a foothold in over 50 countries

33% of our revenue is generated via offshore sales. As well as we have consistently been ranked amongst the top ten pharmaceutical companies in India. Our portfolio includes illustrious brands like Clavam, Pan, Pan-D and Taxim-O, which feature amongst top 50 pharmaceutical brands in India. For over a decade, our dominance in anti-infective segment has remained unchallenged.

We have 21 manufacturing facilities at multiple locations in India and the United States of America. Our upper-crest facilities are inspected and audited as per cGMP guidelines as laid down by leading regulatory authorities such as USFDA, MHRA - UK, SAHPRA-South Africa, TGA - Australia, ANVISA - Brazil, WHO - Geneva, TPD - Health Canada, PPB - Kenya, NDA - Uganda, MOH - Sudan, INVIMA - Colombia, TFDA - Tanzania, Zimbabwe, BfArM-Germany & Other Africa, Asian & CIS Countries.

Another feather in our cap was added on December 23rd, 2015, when, Alkem completed its Initial Public Offering (IPO) and was listed on the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited.

Although, passion is the fuel that keeps ideas alive, innovation is the catalyst that gives it flight! With over 500 scientists working in 6 global R&D centers, we are empowering innovations that align with our philosophy of ‘Extended Lifecare Beyond Boundaries’.

For more updates follow 

www.globalpharmanews.co.in

To get global pharma news updates in whatsapp please 

CLICK HERE

ACCORD LIFE SPEC PVT LTD WALK IN INTERVIEW ON 10th, AUGUST, 2021 @ CHENNAI

ABOUT COMPANY :

Headquartered in Chennai, India, Accord Labs is a fast-growing generic pharmaceutical company with a major focus on development and manufacture of IP led niche finished dosage formulations and Active pharmaceutical ingredients (APIs).

Accord is involved in Research & Development, Manufacturing and Supply of pharmaceuticals across different geographical entities around the globe.

We are always building on our company's core strengths of vertical integration in the fields of discovery, research, process chemistry, active pharmaceutical ingredient production, formulation development and regulatory filings. Accord Pharmaceuticals, is committed to achieving its vision and mission of invariably becoming the most innovation led transnational pharmaceutical company.

Inseminating quintessential aspects into our system to satisfy a wide array of criteria, the accord group always strives to be more and thereby aspire to be the best.Our partnership philosophy with our customers has helped deliver incremental value to both our company and partners.

Fulfilling the demands of the world markets - Accord Pharma aim at building on our strong global footprint, we are committed to fulfilling the demands of the world markets by anticipating the future needs and pioneering strategic new in-roads into the commercial pharmaceutical sector.

Also, we focus on building an enterprise that generates value for all its stakeholders.We are focused on fulfilling the demands of the world markets through different business segments.

For more updates follow 

www.globalpharmanews.co.in

To get global pharma news updates in whatsapp please 

CLICK HERE

For more updates follow 

www.globalpharmanews.co.in

To get global pharma news updates in whatsapp please 

CLICK HERE

COVALENT LABORATORIES LTD WALK ON INTERVIEW ON 1st, AUGUST, 2021 @ HYDERABAD

ABOUT COMPANY :

Covalent Laboratories Private Limited, an ISO 9001:2008 & ISO 14001(2004) accreditated pharmaceutical company and WHO GMP certified for all its products, is specialized in the manufacturing of Cephalosporins.

It has a wide range of products and is fast expanding to meet the present and future market demands for the high value, low volume drugs. Covalent Laboratories manufactures the Active Pharmaceutical Ingredient (API) in bulk quantities for both domestic and international markets. All the drugs manufactured me -ets USP / BP / JP standards.

Covalent Laboratories, which is professionally managed and has well equipped Quality Assurance and Quality Control Lab, focuses on higher production standards for superior quality products that surpass the international standards.

Covalent Laboratories aims at reducing the production cost to give the best price to its customers through its aggre- ssive process development lab.

For more updates follow 

www.globalpharmanews.co.in

To get global pharma news updates in whatsapp please 

CLICK HERE

HEMA LABORATORIES WALK IN INTERVIEW FOR QA DEPARTMENT FROM 1st, AUGUST TO 6th, AUGUST, 2021 @ HYDERABAD

ABOUT COMPANY :

Hema Laboratories was established by K.Siva Rami Reddy in the year 2017,with a grand vision of being the “most preferred supply partner to fulfill the requirements of pharmaceutical customers worldwide

The management aimed to achieve this vision with quality & affordability of products as our highest priority. It is one of the fastest growing manufacturers of Active Pharmaceutical Ingredients (API’S),Intermediates & Specialty chemicals.

Customer Satisfaction is a powerful engine in optimizing the companies profitability through the various imparts it can have, notably on a Quality, Commitment & Affordability Quality is a founding principle at Hema Labs. Since our beginnings,we have placed it at the centre of our concerns, even embedding it in our internal values.

At Hema Laboratories we offer a range of challenging and rewarding career opportunities in an open, diverse and supportive work environment. It is a place where we are free to explore and encouraged to voice new ideas.

As an innovative driven pharmaceutical company with sales US $ 2.8 million, the diversity of job opportunities at Hema runs wide and deep. This is what distinguished us from the rest and inspires us to Excel, Innovate and lead.

The company believes in bringing together the best and the brightest talents it can find in the industry.

If you believe that you can show your talent and sharpen your skills, doors of Hema Laboratories are always open.
Note:you may email your resume to : hr@hemalaboratories.com

For more updates follow 

www.globalpharmanews.co.in

To get global pharma news updates in whatsapp please 

CLICK HERE

GRANULES INDIA LTD WALK IN INTERVIEW FOR FRESHERS TO QC DEPARTMENT ON 02nd, AUGUST, 2021 @ HYDERABAD

ABOUT COMPANY :

Granules India Ltd. is a vertically integrated pharmaceutical company, headquartered in Hyderabad, India. We manufacture Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages (FDs), distributed to quality conscious customers in both regulated and semi-regulated markets. We are dedicated to excellence in manufacturing, quality and customer service.

As Granules stands today, our business is bucketed into three areas; the Core business which comprises our ‘core molecules- Paracetamol, Ibuprofen, Metformin, Guaifenesin and Methocarbamol; the Emerging business that focuses on manufacturing APIs with a focus on vertical integration.

For more updates follow 

www.globalpharmanews.co.in

To get global pharma news updates in whatsapp please 

CLICK HERE

ADMIRON LIFE SCIENCES PVT LTD WALK IN INTERVIEW FOR FRESHERS ON 4th, 5th, AUGUST, 2021 @ VIZAG

ABOUT COMPANY :

Admiron Life Sciences Private Limited is API (Active Pharmaceutical Ingredients) manufacturing facility.

"Admiron Life is a unique API and Advance Intermediates manufacturer; approved and admired by many regulatory authorities and customers globally. We pride ourselves on being known by our customers for our quality, highly reliable and reputed partner for innovation and complex chemistry."

Admiron Life established in 2010 by a team of scientists who had a passion towards chemistry & to ensure a better health to everyone.

Well-equipped standalone Research and Development lab with 15 professional scientists with strong knowledge of chemistry.

Admiron Life is committed to maintain best Quality standards in Research & Development and Manufacturing of pharmaceutical products...

WALK IN DETAILS :

Walk-in Interviews for R&D /QC Freshers @ Visakhapatnam

Admiron Life Sciences Pvt. Ltd. is an APIs manufacturer, looking for suitable candidate for Visakhapatnam Unit.

Department : R&D/QC (Bulk Drugs /API Experience)

Position: Trainee Chemist

Experience : Freshers

Qualification: M. Sc Organic chemistry

Job Location: Visakhapatnam

Interview Venue:

Admiron Life Sciences Pvt Ltd 

Plot no: 11 JNPC, Parawada,

Visakhapatnam Dt,

AP, India-531019,

Contact: A. Poleswarrao

Executive HR

Mobile: +91 79958 33388

Date & Time:

August 4 and 5, 2021(Wednesday, Thursday) @ 10:00 AM – 02:00 PM

Note: Male candidates are preferred, willing to join immediately and also willing to work in Shifts.

Candidates has to Carry:

1) Updated Resume.

2) Education Certificates

Candidates who are unable to attend the interview can send Profiles to Email: 

hr@admironls.in

hr.corporate@pranayagroup.com

For more updates follow 

www.globalpharmanews.co.in

To get global pharma news updates in whatsapp please 

CLICK HERE

MAITHRI DRUGS PVT LTD WALK IN DRIVE FOR FRESHERS & EXPERIENCE CANDIDATES ON 2nd, AUGUST, 2021 @ HYDERABAD

                                                         

ABOUT COMPANY :

Maithri Drugs is one of India's fast-growing pharmaceutical companies. Maithri's strategic focus is on active pharma ingredients (APIs). The company is widely recognized for its excellent research & development and aggressive growth strategies. Our 30 US DMFs and 9 CEPs in a short span attest to our R&D excellence.

Maithri's manufacturing facility is located in Hyderabad. This facility is audited and approved by the US FDA. In addition, our facility is certified according to the standards of  DCGI, WHO GMP, and ISO 9001:2015 We have a portfolio of 65 products and are continually expanding. Our products cover a broad range of therapeutic categories including CNS, anti-anaemics, anti-bacterial, anti-diabetic, anti-fungal, anti-hyperthyroidism, anti-inflammatory, anti-viral, antihypertensive, cardiovascular, etc. 

Maithri Drugs serves hundreds of customers spread across 35 countries. We have a constant goal of producing high-quality products and providing unparalleled customer service.

VACANCY DETAILS :

Dear Team,

Maithri Drugs R&D Technology Center, Gummadidala: R&D (API) Department walk-in drive on 02/08/2021

VACANCIES: Trainee's (Fresher's)/ Junior Executive’s/ Executive’s/ Senior Executive's

QUALIFICATION: B.Sc (Chemistry)/ M.Sc (Organic Chemistry)

ELIGIBILITY CRITERIA: 0-7 yrs of work experience -  B.Pharm & M.Pharm candidates are NOT ELIGIBLE

JOB REQUIREMENTS:
1. Need to have sound knowledge in API R&D.
2. Need to have experience in process developmemt R&D

DOCUMENTS TO BE CARRIED: Candidates are requested to carry updated resume, photocopies of educational certificates, latest increment letter, last 3 months pay slips, last 6 months bank statement and photocopy of aadhar card.

TIMINGS: Interested candidates may walk-in from 09:00 AM to 01:00 PM

INTERVIEW VENUE & JOB LOCATION:  Maithri Drugs R&D Technology Center, Gummadidala. Landmark:  2nd gate beside IPC Church, Gummadidala

For more updates follow 

www.globalpharmanews.co.in

To get global pharma news updates in whatsapp please 

CLICK HERE

AUROBINDO PHARMA LTD HIRING CANDIDATES FOR QA DEPARTMENT (IPQA/ QMS/ VALIDATION/ CSV ) @ NAIDUPETA , NELLORE

                   

                                           

ABOUT COMPANY :

Founded in 1986 by Mr. P. V. Ramprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born of a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry.

Aurobindo Pharma became a public company in 1992 and listed its shares on the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and anti-biotics, among others.

VACANCY DETAILS :

Send Resumes Who are willing to relocate Nayudupeta Only 

Send RESUMES On and before 01/08/2021

COMPANY : Aurobindo Pharma Ltd

JOB LOCATION : Nayudupeta , Nellore (Dt), Andra Pradesh

DEVISON : Formulation

DEPARTMENTS: QUALITY ASSURANCE 

Designation :  Executive/ Sr.executive

QUALIFICATION : B.Pharm/ M.Pharm

             

EXPERIENCE : Should have minimum experience of 4- 10 years.

Quality Assurance: Executives/ Senior Executives

(Qualifications – CSV / Equipment /QMS/IPQA)

 

Analytical Quality Assurance: Executives/ Senior Executives

Candidate with 4 – 10 years of formulations experience & should have USFDA or other Regulatory audits exposure.

In subject Mention your " AUROBINDO"

Interest candidates send resume to globalpharmanews@gmail.com

For more updates follow 

www.globalpharmanews.co.in

To get global pharma news updates in whatsapp please 

CLICK HERE

MAITHRI DRUGS PVT LTD WALK IN DRIVE FOR QA DEPARTMENT ON 31st, JULY, 2021 @ HYDERABAD

                                                       

ABOUT COMPANY :

Maithri Drugs is one of India's fast-growing pharmaceutical companies. Maithri's strategic focus is on active pharma ingredients (APIs). The company is widely recognized for its excellent research & development and aggressive growth strategies. Our 30 US DMFs and 9 CEPs in a short span attest to our R&D excellence.

Maithri's manufacturing facility is located in Hyderabad. This facility is audited and approved by the US FDA. In addition, our facility is certified according to the standards of  DCGI, WHO GMP, and ISO 9001:2015 We have a portfolio of 65 products and are continually expanding. Our products cover a broad range of therapeutic categories including CNS, anti-anaemics, anti-bacterial, anti-diabetic, anti-fungal, anti-hyperthyroidism, anti-inflammatory, anti-viral, antihypertensive, cardiovascular, etc. 

Maithri Drugs serves hundreds of customers spread across 35 countries. We have a constant goal of producing high-quality products and providing unparalleled customer service.

VACANCY DETAILS :

Maithri Drugs Private Limited, Bonthapally: QA Department walk-in drive on 31/07/2021

VACANCIES: Assistant Manager/ Deputy Manager

QUALIFICATION: M.Sc/ M.Pharm/ B.Sc/ B.Pharm

ELIGIBILITY CRITERIA: 10-15 yrs of work experience in pharma industry

JOB REQUIREMENTS:
1. Knowledge on OOS, OOT's, Deviations and need to establish the CAPA.
2. Need to evaluate the risk assessments as part of Integrated Quality Management, Facilities, Equipment and Utilities, Materials Management.
3. Need to interact with various regulatory health authorities regarding Submission / Amendment / Variations / Approvals etc..,
4. Should be able to face the regulatory authority and customer audits
5. Preparing and Reviewing of SOP's, STP's, process and method related documents.
6. Knowledge in handling quality related complaints, return goods and recalls.
7. To verify the change management and approving impact on changes that potentially impact intermediate or API quality.
8. To verify product quality reviews.
9. Should be well versed with water system qualifications, clean room qualifications and air handling unit qualifications.
10.Should have through knowledge on QMS systems and should be able to handle quality assurance department.

DOCUMENTS TO BE CARRIED: Candidates are requested to carry updated resume, photocopies of educational certificates, latest increment letter, last 3 months pay slips, last 6 months bank statement and photocopy of aadhar card.

TIMINGS: Interested candidates may walk-in from 09:00 AM to 01:00 PM

INTERVIEW VENUE & WORK LOCATION: Maithri Drugs Pvt Ltd, Bonthapally, Landmark: Lane Beside Bharat Petroleum Bunk, Bonthapally

For more updates follow 

www.globalpharmanews.co.in

To get global pharma news updates in whatsapp please 

CLICK HERE

JODAS EXPOIM PVT LTD WALK IN INTERVIEW FOR FRESHERS (M.PHARMACY/ B.PHARMACY/ M.Sc) ON 31st, JULY, 2021 @ SIDDIPETA, TELANGANA

ABOUT COMPANY :

Jodas is a Global, specialty, innovation driven, emerging, generic pharmaceutical company, that is asserting itself among the world’s foremost pharmaceutical companies. We began our journey of growth in the year 2006 in India, and today Jodas is a modern, research driven organization that has quality and affordability at the heart of its activities.

Jodas focuses its operations on four speciality therapeutic segments:

·         Anti Infectives (Injectables & Orals)

·         Anti Cancer (Injectables & Orals)

·         Contrast Media – Injectables

·         Critical Care (Injectables & Orals)

Our dedicated team of healthcare professionals strives to bring specialty, high-quality, effective and affordable generic formulations to the market, touching millions of lives with good health.

Jodas has 40+ approved products in targeted emerging markets with State-of-the-art world-class manufacturing facilities and has successfully commercialized 7 million Injectables in the year 2014, with unparalleled customer satisfaction.

Focused to grow further in Emerging markets. The future endeavor is to be a Global generic player in highly regulated markets. We are committed to be “ONE STEP BETTER”, to fulfill the unmet medical needs of the healthcare community around the Globe with branded generic formulations of uncompromising quality.

Jodas has constantly upped the benchmark in uncompromising quality, with a pulse on rapidly changing innovation to commercialization landscape through our selection of a product range of affordable medicines and speed-to-the-market, along with our partners and Global supply chain.

We continuously evolve our business focus with a customer–centered portfolio of niche and technologically challenging products from specialty and therapeutic segments.

Our continuous focus on innovation and quality drives us to fulfill the unmet medical needs of the healthcare community and make the dreams of millions of people across the world come true with much needed medicines at an affordable value.

For more updates follow 

www.globalpharmanews.co.in

To get global pharma news updates in whatsapp please 

CLICK HERE